Details for gene set CMV_ALL

Table: GSEA Results Summary

Dataset	double_gel_and_single_gel_rma_expression_values_collapsed_to_symbols.class.cls #double_gel_8d_versus_double_gel_72h.class.cls #double_gel_8d_versus_double_gel_72h_repos
Phenotype	class.cls#double_gel_8d_versus_double_gel_72h_repos
Upregulated in class	double_gel_8d
GeneSet	CMV_ALL_DN
Enrichment Score (ES)	0.5731543
Normalized Enrichment Score (NES)	1.9814205
Nominal p-value	0.0
FDR q-value	0.0067555592
FWER p-Value	0.267

Table: GSEA details [plain text format]
	PROBE	GENE SYMBOL	GENE_TITLE	RANK IN GENE LIST	RANK METRIC SCORE	RUNNING ES	CORE ENRICHMENT
1	COL1A2	COL1A2 Entrez, Source	collagen, type I, alpha 2	3	1.046	0.1010	Yes
2	ANXA1	ANXA1 Entrez, Source	annexin A1	10	0.815	0.1795	Yes
3	SERPINE1	SERPINE1 Entrez, Source	serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1	12	0.803	0.2571	Yes
4	COL3A1	COL3A1 Entrez, Source	collagen, type III, alpha 1 (Ehlers-Danlos syndrome type IV, autosomal dominant)	15	0.737	0.3283	Yes
5	COL5A2	COL5A2 Entrez, Source	collagen, type V, alpha 2	28	0.668	0.3920	Yes
6	ADM	ADM Entrez, Source	adrenomedullin	34	0.649	0.4544	Yes
7	CFD	CFD Entrez, Source	complement factor D (adipsin)	337	0.234	0.4543	Yes
8	LAMB2	LAMB2 Entrez, Source	laminin, beta 2 (laminin S)	351	0.229	0.4755	Yes
9	TIMP3	TIMP3 Entrez, Source	TIMP metallopeptidase inhibitor 3 (Sorsby fundus dystrophy, pseudoinflammatory)	406	0.208	0.4916	Yes
10	COL6A2	COL6A2 Entrez, Source	collagen, type VI, alpha 2	460	0.193	0.5063	Yes
11	IGF2	IGF2 Entrez, Source	insulin-like growth factor 2 (somatomedin A)	480	0.186	0.5228	Yes
12	TGFBR3	TGFBR3 Entrez, Source	transforming growth factor, beta receptor III (betaglycan, 300kDa)	577	0.168	0.5319	Yes
13	AR	AR Entrez, Source	androgen receptor (dihydrotestosterone receptor; testicular feminization; spinal and bulbar muscular atrophy; Kennedy disease)	602	0.164	0.5459	Yes
14	COL1A1	COL1A1 Entrez, Source	collagen, type I, alpha 1	738	0.146	0.5499	Yes
15	NR2F2	NR2F2 Entrez, Source	nuclear receptor subfamily 2, group F, member 2	806	0.139	0.5583	Yes
16	WEE1	WEE1 Entrez, Source	WEE1 homolog (S. pombe)	1001	0.121	0.5554	Yes
17	SGCG	SGCG Entrez, Source	sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein)	1085	0.116	0.5603	Yes
18	SULT1E1	SULT1E1 Entrez, Source	sulfotransferase family 1E, estrogen-preferring, member 1	1236	0.108	0.5595	Yes
19	ZFP36L1	ZFP36L1 Entrez, Source	zinc finger protein 36, C3H type-like 1	1350	0.101	0.5607	Yes
20	HNMT	HNMT Entrez, Source	histamine N-methyltransferase	1378	0.100	0.5684	Yes
21	ACTA2	ACTA2 Entrez, Source	actin, alpha 2, smooth muscle, aorta	1439	0.096	0.5732	Yes
22	CHN1	CHN1 Entrez, Source	chimerin (chimaerin) 1	1627	0.088	0.5676	No
23	MARCKS	MARCKS Entrez, Source	myristoylated alanine-rich protein kinase C substrate	1688	0.085	0.5713	No
24	BMP4	BMP4 Entrez, Source	bone morphogenetic protein 4	1840	0.078	0.5675	No
25	ANP32A	ANP32A Entrez, Source	acidic (leucine-rich) nuclear phosphoprotein 32 family, member A	2279	0.065	0.5408	No
26	BCL2	BCL2 Entrez, Source	B-cell CLL/lymphoma 2	2324	0.064	0.5437	No
27	RALGDS	RALGDS Entrez, Source	ral guanine nucleotide dissociation stimulator	2700	0.055	0.5208	No
28	IGFBP5	IGFBP5 Entrez, Source	insulin-like growth factor binding protein 5	2713	0.055	0.5252	No
29	CXCR7	CXCR7 Entrez, Source	chemokine (C-X-C motif) receptor 7	2822	0.052	0.5221	No
30	CDH11	CDH11 Entrez, Source	cadherin 11, type 2, OB-cadherin (osteoblast)	2961	0.050	0.5165	No
31	CDC25B	CDC25B Entrez, Source	cell division cycle 25B	3066	0.047	0.5132	No
32	ADRA2A	ADRA2A Entrez, Source	adrenergic, alpha-2A-, receptor	3082	0.047	0.5166	No
33	IGF1R	IGF1R Entrez, Source	insulin-like growth factor 1 receptor	3414	0.040	0.4956	No
34	MATK	MATK Entrez, Source	megakaryocyte-associated tyrosine kinase	4259	0.026	0.4345	No
35	ACVR2A	ACVR2A Entrez, Source	activin A receptor, type IIA	4325	0.025	0.4320	No
36	TNFRSF1A	TNFRSF1A Entrez, Source	tumor necrosis factor receptor superfamily, member 1A	4794	0.018	0.3985	No
37	ACO1	ACO1 Entrez, Source	aconitase 1, soluble	4901	0.017	0.3921	No
38	RAB13	RAB13 Entrez, Source	RAB13, member RAS oncogene family	5027	0.015	0.3842	No
39	CEBPD	CEBPD Entrez, Source	CCAAT/enhancer binding protein (C/EBP), delta	5268	0.012	0.3672	No
40	EPO	EPO Entrez, Source	erythropoietin	5541	0.008	0.3474	No
41	FGF7	FGF7 Entrez, Source	fibroblast growth factor 7 (keratinocyte growth factor)	5875	0.004	0.3227	No
42	TPM1	TPM1 Entrez, Source	tropomyosin 1 (alpha)	5926	0.003	0.3192	No
43	CRHBP	CRHBP Entrez, Source	corticotropin releasing hormone binding protein	7209	-0.013	0.2239	No
44	PDGFRA	PDGFRA Entrez, Source	platelet-derived growth factor receptor, alpha polypeptide	7343	-0.015	0.2153	No
45	DDR2	DDR2 Entrez, Source	discoidin domain receptor family, member 2	7491	-0.017	0.2058	No
46	ZCCHC9	ZCCHC9 Entrez, Source	zinc finger, CCHC domain containing 9	7662	-0.019	0.1948	No
47	AHR	AHR Entrez, Source	aryl hydrocarbon receptor	7804	-0.021	0.1862	No
48	ENG	ENG Entrez, Source	endoglin (Osler-Rendu-Weber syndrome 1)	8089	-0.025	0.1672	No
49	CCND1	CCND1 Entrez, Source	cyclin D1	8524	-0.031	0.1375	No
50	ANPEP	ANPEP Entrez, Source	alanyl (membrane) aminopeptidase (aminopeptidase N, aminopeptidase M, microsomal aminopeptidase, CD13, p150)	8993	-0.037	0.1059	No
51	PTGIS	PTGIS Entrez, Source	prostaglandin I2 (prostacyclin) synthase	9012	-0.038	0.1082	No
52	HIVEP2	HIVEP2 Entrez, Source	human immunodeficiency virus type I enhancer binding protein 2	9216	-0.040	0.0968	No
53	THBS2	THBS2 Entrez, Source	thrombospondin 2	9270	-0.041	0.0968	No
54	C1R	C1R Entrez, Source	complement component 1, r subcomponent	10107	-0.055	0.0391	No
55	CSPG2	CSPG2 Entrez, Source	chondroitin sulfate proteoglycan 2 (versican)	10417	-0.061	0.0217	No
56	HSD17B2	HSD17B2 Entrez, Source	hydroxysteroid (17-beta) dehydrogenase 2	10438	-0.061	0.0261	No
57	PAFAH1B1	PAFAH1B1 Entrez, Source	platelet-activating factor acetylhydrolase, isoform Ib, alpha subunit 45kDa	10816	-0.069	0.0043	No
58	CYP1B1	CYP1B1 Entrez, Source	cytochrome P450, family 1, subfamily B, polypeptide 1	10964	-0.073	0.0003	No
59	PABPC1	PABPC1 Entrez, Source	poly(A) binding protein, cytoplasmic 1	10990	-0.073	0.0055	No
60	IGFBP2	IGFBP2 Entrez, Source	insulin-like growth factor binding protein 2, 36kDa	11121	-0.076	0.0031	No
61	RUNX1	RUNX1 Entrez, Source	runt-related transcription factor 1 (acute myeloid leukemia 1; aml1 oncogene)	11134	-0.077	0.0096	No
62	NR3C1	NR3C1 Entrez, Source	nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)	11271	-0.081	0.0071	No
63	ITSN1	ITSN1 Entrez, Source	intersectin 1 (SH3 domain protein)	11645	-0.090	-0.0123	No
64	AARS	AARS Entrez, Source	alanyl-tRNA synthetase	11763	-0.094	-0.0120	No
65	MAPK14	MAPK14 Entrez, Source	mitogen-activated protein kinase 14	12051	-0.105	-0.0235	No
66	EFEMP1	EFEMP1 Entrez, Source	EGF-containing fibulin-like extracellular matrix protein 1	12182	-0.111	-0.0226	No
67	TSPAN6	TSPAN6 Entrez, Source	tetraspanin 6	12432	-0.123	-0.0294	No
68	MYH9	MYH9 Entrez, Source	myosin, heavy chain 9, non-muscle	12494	-0.127	-0.0217	No
69	GPX1	GPX1 Entrez, Source	glutathione peroxidase 1	12567	-0.133	-0.0143	No
70	DDIT4	DDIT4 Entrez, Source	DNA-damage-inducible transcript 4	12743	-0.146	-0.0134	No
71	CXCL12	CXCL12 Entrez, Source	chemokine (C-X-C motif) ligand 12 (stromal cell-derived factor 1)	12892	-0.163	-0.0088	No
72	ID2	ID2 Entrez, Source	inhibitor of DNA binding 2, dominant negative helix-loop-helix protein	13029	-0.193	-0.0003	No
73	MBL2	MBL2 Entrez, Source	mannose-binding lectin (protein C) 2, soluble (opsonic defect)	13189	-0.247	0.0115	No